Skip to main content
Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · IEX Real-Time Price · USD
36.08
+0.66 (1.86%)
At close: Jul 26, 2024, 4:00 PM
37.54
+1.46 (4.05%)
After-hours: Jul 26, 2024, 7:11 PM EDT

Collegium Pharmaceutical Revenue

Collegium Pharmaceutical had revenue of $144.92M in the quarter ending March 31, 2024, with 0.11% growth. This brings the company's revenue in the last twelve months to $566.92M, up 8.00% year-over-year. In the year 2023, Collegium Pharmaceutical had annual revenue of $566.77M with 22.17% growth.

Revenue (ttm)
$566.92M
Revenue Growth
+8.00%
P/S Ratio
2.08
Revenue / Employee
$2,877,782
Employees
197
Market Cap
1.18B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023566.77M102.83M22.17%
Dec 31, 2022463.93M187.07M67.56%
Dec 31, 2021276.87M-33.15M-10.69%
Dec 31, 2020310.02M13.32M4.49%
Dec 31, 2019296.70M16.29M5.81%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AtriCure 414.60M
Artivion 368.21M
Innoviva 311.59M
Maravai LifeSciences Holdings 274.10M
Silk Road Medical 185.49M
Arcutis Biotherapeutics 106.39M
Autolus Therapeutics 10.50M
Revenue Rankings

COLL News

More News